Treatment of Ocular Discomfort in Glaucoma Patients Using Multiple Topical Medications

Recruiting now

Conditions studied: Glaucoma, Ocular Surface Disease

In brief

To evaluate glaucoma patients' response to treatment with Xiidra, an FDA-approved drug for ocular surface discomfort, which will be prescribed as standard of care treatment.

Key facts

Study ID

NCT04354545

Run by

University of California, Los Angeles

People needed

75

Starts

2021-04-01

Expected to finish

2026-12-01

Last updated by the study team

2026-03-13

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Currently using one or more topical glaucoma antihypertensives
• Self-described symptoms of ocular surface discomfort
• Xiidra is being prescribed as part of the subject's standard care

You may not qualify if…

• History of glaucoma filtration surgery, history of ocular surface surgery (pterygium, conjunctivoplasty, etc.),
• current use of topical cyclosporine
• current use of topical steroids
• incisional ocular surgery within 6 months

Where it is running

• Doheny Eye Center UCLA — Fountain Valley, California, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.